ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Total liabilities 2018–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) total liabilities at each fiscal year-end, per SEC filings.
$287.7MFY2025 · since FY2018: $29.9M → $287.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $287.7M | -14.6% |
| FY2024 | $336.9M | -4.5% |
| FY2023 | $352.9M | -10.1% |
| FY2022 | $392.5M | +23.0% |
| FY2021 | $319.2M | -14.4% |
| FY2020 | $373.1M | +9.3% |
| FY2019 | $341.3M | +1039.7% |
| FY2018 | $29.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADPT financial trends
ADPT RevenueADPT Net incomeADPT Net marginADPT Gross profitADPT Gross marginADPT Operating incomeADPT Operating marginADPT Operating cash flowADPT Free cash flowADPT Capital expendituresADPT Return on equityADPT Stock buybacksADPT Dividends paidADPT Total assetsADPT Shareholders’ equityADPT overview →